TAG:
managed care plan
Clarient, Generation Health, GenMark, Osmetech, Laboratoire Cerba, UCLA Med Center
By Robert Michel | From the Volume XVII No. 9 – June 21, 2010 Issue
CLARIENT INKS PACT WITH GENERATION HEALTH FOR GENETIC TESTING PAYER PRE-AUTHORIZATION OF GENETIC TESTS is the reason for the newly-announced contract between Clarient, Inc., and Generation Health, Inc., of Upper Saddle River, New Jersey. An…
Halfpenny Technologies Buys Laboratory Management Services
By Robert Michel | From the Volume XVII No. 9 – June 21, 2010 Issue
TO BROADEN ITS CAPABILITIES in handling laboratory test data, Halfpenny Technologies, Inc., announced the acquisition of Laboratory Management Services (LMS) of Hauppauge, New York, earlier this month. Halfpenny seems to be particularly interested in the informatics…
AG Jerry Brown Settles With Westcliff Med Labs
By Robert Michel | From the Volume XVII No. 8 – June 1, 2010 Issue
CEO SUMMARY: In California, Attorney General Jerry Brown is making progress in the whistleblower lawsuit alleging that seven lab companies in California violated state law by not giving Medi-Cal, the state’s Medicaid program, the same lowest lab test prices they extend to physi…
Pre-authorization Coming For Pricey Molecular Tests
By Robert Michel | From the Volume XVII No. 6 – April 19, 2010 Issue
CEO SUMMARY: In response to the steep ramp-up in the utilization of genetic and molecular testing, the nation’s largest health insurers are preparing to institute new guidelines for coverage and reimbursement. These will include pre-authorization by physicians, a more effective genetic …
Textbook Marketing Fuels Demand for BRCA Test
By Robert Michel | From the Volume XVI No. 13 – September 21, 2009 Issue
CEO SUMMARY: In today’s lab testing marketplace, the hot ticket is to introduce a proprietary or patent-protected molecular test for cancer. The sales and marketing model inspiring many of these new lab testing companies is that used by Myriad Genetics, Inc. since it introduced…
Local Labs Have Opportunities To Increase MC Patient Access
By Robert Michel | From the Volume XVI No. 3 – February 23, 2009 Issue
CEO SUMMARY: Although the nation’s two largest laboratory companies have achieved a dominant managed care position, opportunities remain for regional labs to do more business with managed care plans. Two experts provide an update of managed care pricing trends for labo…
Successful Laboratories in the Future Will Brand Themselves, Add Value
By Robert Michel | From the Volume XV No. 11 – August 18, 2008 Issue
“There is an opportunity for the laboratories to become more proactive with health plans. Pathologists are reading the literature and know specifically which diagnostics tests should be performed before expensive imaging procedures are ordered.” —Kerry Kaplan, Presid…
Lab Testing Hits Two Home Runs For Patients
By R. Lewis Dark | From the Volume XV No. 10 – July 28, 2008 Issue
MANY OF US POINT OUT THAT LABORATORY MEDICINE is an undervalued and under-utilized asset within the American healthcare system. Lab testing is generally a minimal cost relative to the total episode of care, yet lab testing provides essential knowledge to help clinicians make a quick, accurate diagnos…
An Economic Perspective On Discounted PC Deals
By Robert Michel | From the Volume XIV No. 13 – September 17, 2007 Issue
CEO SUMMARY: By opening their own in-office pathology laboratories, specialist physicians are undermining a long-established referral relationship with the pathology profession. Pathologists are debating the merits of this market-based trend and its effect on their profession. However thi…
Exclusive Lab Contracts Have Consequences
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: During the past seven months, competition in the Northeast has intensified. Decisions by UnitedHealth and Aetna to exclude a national laboratory from their respective provider panels has forced many physicians to reconsider their choice of laboratory provider—creating an op…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized